The pharma giant recently announced a partnership with the Professional Pickleball Association (PPA) to help raise awareness for its eosinophilic asthma biologic Fasenra. The collaboration is a ...

AstraZeneca’s asthma drug Fasenra also works in a group of rare diseases that can lead to potentially fatal organ damage, a mid-stage trial has shown. Results of the phase 2 trial, published in ...

FASENRA® (benralizumab) injection for subcutaneous use is approved for the treatment of adults with EGPA. For the treatment of EGPA, the recommended dosage of FASENRA is 30 mg (one injection ...

AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. The injectable drug will serve as an official partner of the Professional ...

AstraZeneca has gained approval for its Fasenra asthma drug in Europe, while Vertex’s cystic fibrosis drug Orkambi has received an expanded use in children with cystic fibrosis. AZ said Fasenra ...

AstraZeneca AZN stock has declined 14% in the past three months. A lot of this price decline is due to ongoing investigations at its China subsidiary. However, the overall drug and biotech sector has ...

Revenues increased across all segments, with sales of most of the key drugs, including Tagrisso, Fasenra, Farxiga, Lynparza and Symbicort, beating estimates. The British drugmaker said that the ...